Thymalin (Thymus Extract)

Overview

Thymalin is a natural peptide bioregulator derived from calf thymus gland, developed in the Soviet Union in the 1970s. It contains a mixture of thymic peptides that support immune restoration, anti-aging, and tissue regeneration. Research spanning decades has shown significant geroprotective effects, with studies demonstrating up to 2-fold reduction in mortality rates and 4-fold reduction when combined with Epithalamin.

Thymalin's immunoprotective action stems from short peptides (KE, EW, EDP) that specifically bind to double-stranded DNA and histone proteins to regulate gene expression. It stimulates differentiation and activity of T-lymphocytes, especially CD4+ and CD8+ cells, promotes cytokine regulation, enhances antigen response, and stimulates stem cell differentiation. It also affects gerontogene activity and immune system protein synthesis.

Stimulates T-lymphocyte differentiation and activity for comprehensive immune system restoration.

Accelerates recovery of lymphocyte populations including CD4+, CD3+HLA-DR+, B-cells, and NK-cells.

2.0-2.4 fold reduction in acute respiratory disease incidence in elderly patients.

Clinical studies showed 2.0-2.1 fold mortality reduction over 6-8 years in treated elderly.

Mechanism

Thymalin is a natural peptide bioregulator derived from calf thymus gland, developed in the Soviet Union in the 1970s. It contains a mixture of thymic peptides that support immune restoration, anti-aging, and tissue regeneration. Research spanning decades has shown significant geroprotective effects, with studies demonstrating up to 2-fold reduction in mortality rates and 4-fold reduction when combined with Epithalamin.

Thymalin's immunoprotective action stems from short peptides (KE, EW, EDP) that specifically bind to double-stranded DNA and histone proteins to regulate gene expression. It stimulates differentiation and activity of T-lymphocytes, especially CD4+ and CD8+ cells, promotes cytokine regulation, enhances antigen response, and stimulates stem cell differentiation. It also affects gerontogene activity and immune system protein synthesis.

Stimulates T-lymphocyte differentiation and activity for comprehensive immune system restoration.

Research areas

• Thymalin is a natural peptide bioregulator derived from calf thymus gland, developed in the Soviet Union in the 1970s. It contains a mixture of thymic peptides that support immune restoration, anti-aging, and tissue regeneration. Research spanning decades has shown significant geroprotective effects, with studies demonstrating up to 2-fold reduction in mortality rates and 4-fold reduction when combined with Epithalamin.
• Thymalin's immunoprotective action stems from short peptides (KE, EW, EDP) that specifically bind to double-stranded DNA and histone proteins to regulate gene expression. It stimulates differentiation and activity of T-lymphocytes, especially CD4+ and CD8+ cells, promotes cytokine regulation, enhances antigen response, and stimulates stem cell differentiation. It also affects gerontogene activity and immune system protein synthesis.
• Stimulates T-lymphocyte differentiation and activity for comprehensive immune system restoration.
• Accelerates recovery of lymphocyte populations including CD4+, CD3+HLA-DR+, B-cells, and NK-cells.
• 2.0-2.4 fold reduction in acute respiratory disease incidence in elderly patients.
• Clinical studies showed 2.0-2.1 fold mortality reduction over 6-8 years in treated elderly.
• Normalizes basic body functions and improves cardiovascular, endocrine, immune, and nervous systems.
• When combined with Epithalamin for 6 years, mortality decreased 4.1 times vs control.
• Faster reversal of lymphopenia and immune marker recovery in severe COVID-19 patients.
• Tumor growth arrest and regression observed in over half of animals in sarcoma studies.
• Normalizes thymus function during aging process.

Research notes

• Injection site reactions (mild)
• Practically no side effects reported
• Signs of allergic reaction
• Unusual immune responses
• Autoimmune diseases (use with caution)
• Organ transplant recipients (immunosuppression needed)
• Pregnancy or breastfeeding
• Known hypersensitivity

Reported effects in literature

• Clinical studies showed 2.0-2.1 fold mortality reduction over 6-8 years in elderly patients. When combined with Epithalamin, the reduction reached 4.1 fold - one of the most significant longevity effects documented for peptide bioregulators, though these were observational studies rather than randomized trials.

FAQs